NMN and NR both raise NAD+ in humans, and both have been well tolerated in trials. The difference is what each one has been shown to move after that. NMN carries the stronger published results on insulin sensitivity and walking distance. NR carries the longer safety record and the first proof of oral delivery. For most US buyers, NMN is the better-evidenced pick.
That is the answer. The reasoning matters more, because almost every NMN vs NR comparison online argues from chemistry — which molecule sits closer to NAD+ on a metabolic map — and never opens the human trials. Six of those trials are published. They disagree with the chemistry argument in one specific, useful way.
What NMN and NR Actually Are
NMN (β-nicotinamide mononucleotide) and NR (nicotinamide riboside) are both precursors to NAD+, the coenzyme your cells use for energy production and DNA repair. NAD+ itself is too large a molecule to swallow usefully, so supplements deliver a precursor and let your cells finish the job.
NR is one chemical step further from NAD+ than NMN. Inside the cell, NR gets converted to NMN, and NMN gets converted to NAD+. That single fact is what the entire "NMN is closer, so NMN is better" argument rests on, and it is the argument the trials complicate. NR has the older and larger human evidence base, because it reached the US supplement market first and attracted trial funding earlier.
Both are sold in the US as dietary supplements under structure/function rules, meaning a label may describe support for normal body function but may not claim to treat or prevent disease.
What the NR Trials Found
The NR evidence is broad on safety and NAD+ chemistry, and thin on outcomes people can feel.
The first human pharmacokinetic trial established the basic case: NR is orally bioavailable in humans and raises the NAD+ metabolome, with a compound called NAAD emerging as a sensitive marker of genuine NAD+ repletion (Trammell 2016, Nature Communications). That paper is why NR is in the conversation at all.
A 2 × 6-week randomised crossover trial in healthy middle-aged and older adults then confirmed that chronic NR supplementation is well tolerated and effectively stimulates NAD+ metabolism (Martens 2018, Nature Communications). The authors framed their physiological findings as initial insight pointing toward future trials, not as a settled effect.
A third trial gave 12 aged men 1 g of NR daily for 21 days. It raised the skeletal-muscle NAD+ metabolome and produced anti-inflammatory transcriptomic signatures — but it did not deliver the improvement in muscle mitochondrial bioenergetics the researchers set out to find (Elhassan 2019, Cell Reports).
The fourth is the one that changed how careful readers weigh NR. Forty obese, insulin-resistant men aged 40–70 took 1,000 mg of NR twice daily — 2,000 mg a day — for 12 weeks. Insulin sensitivity, endogenous glucose production, glucose disposal and glucose oxidation were not improved. Neither was resting energy expenditure, lipolysis, lipid oxidation, or body composition. The trial's own conclusion is that 2,000 mg/day of NR appears safe but does not improve insulin sensitivity or whole-body glucose metabolism in this group (Dollerup 2018, American Journal of Clinical Nutrition).
Four NR trials, and the pattern holds: NAD+ chemistry moves reliably, downstream function does not.
What the NMN Trials Found
The NMN evidence is younger and smaller, and it reaches further into outcomes.
A 10-week randomised, placebo-controlled, double-blind trial gave 250 mg of NMN daily to postmenopausal women with prediabetes who were overweight or obese. Insulin-stimulated glucose disposal, measured with a hyperinsulinaemic-euglycaemic clamp, increased after NMN and did not change on placebo. Skeletal-muscle insulin signalling increased alongside it (Yoshino 2021, Science). The clamp is the reference method for measuring insulin sensitivity, which is what makes this result hard to wave away.
A second trial ran a dose ladder. Eighty healthy middle-aged adults took placebo, 300 mg, 600 mg or 900 mg of NMN once daily for 60 days. Blood NAD+ rose significantly in every NMN group at day 30 and day 60, highest at 600 mg and 900 mg. Six-minute walking distance improved significantly against placebo in all three dose groups at both time points, with the longest distances at 600 mg and 900 mg. All 80 participants completed the trial with no safety issues found (Yi 2023, GeroScience).
Two NMN trials, both placebo-controlled, both reporting a functional endpoint moving — not just a blood marker.
NMN vs NR: The Six Trials Side by Side
| Trial | Compound & daily dose | Who | Length | What moved | What did not |
|---|---|---|---|---|---|
| Trammell 2016 | NR, single-dose pharmacokinetics | Healthy adults | Acute | Oral bioavailability confirmed; NAD+ metabolome up; NAAD identified as a repletion marker | Not designed to test any functional outcome |
| Martens 2018 | NR, 1,000 mg | Healthy middle-aged & older adults | 2 × 6 weeks, crossover | NAD+ metabolism stimulated; well tolerated | Physiological effects reported as initial insight only, not established |
| Elhassan 2019 | NR, 1,000 mg | 12 aged men | 21 days | Muscle NAD+ metabolome up; anti-inflammatory gene signatures | Muscle mitochondrial bioenergetics — the stated aim |
| Dollerup 2018 | NR, 2,000 mg | 40 obese, insulin-resistant men, 40–70 | 12 weeks | Safety blood tests normal; no serious adverse events | Insulin sensitivity, glucose disposal, energy expenditure, lipolysis, body composition — none improved |
| Yoshino 2021 | NMN, 250 mg | Postmenopausal women with prediabetes, overweight or obese | 10 weeks | Muscle insulin sensitivity by clamp; muscle insulin signalling | Trial did not test physical performance |
| Yi 2023 | NMN, 300 / 600 / 900 mg | 80 healthy middle-aged adults | 60 days | Blood NAD+ at every dose; 6-minute walk distance at every dose | No safety signal found at any dose tested |
OUR VERDICT
If you want the compound with published human results on insulin sensitivity and walking distance, buy NMN — and pair it with TMG. Choose NR only if you specifically want the molecule with the longest safety record and are content with a raised NAD+ marker as the outcome.
The Dose Gap Most NMN vs NR Comparisons Skip
Read the table's two metabolic trials next to each other. The NR trial that found nothing on insulin sensitivity used 2,000 mg a day for 12 weeks. The NMN trial that did find something used 250 mg a day for 10 weeks — one eighth of the dose, for a shorter time.
This is not a head-to-head result, and treating it as one would be dishonest. The two trials recruited different people: obese insulin-resistant men in one, postmenopausal prediabetic women in the other. Population differences alone can explain a split like this, and no trial has yet run NMN and NR against each other in the same room.
What the gap does rule out is the most common sales argument on both sides — that the answer is simply more milligrams. NR at eight times the dose did not buy the outcome NMN produced at 250 mg. Anyone selling you a higher-milligram bottle as self-evidently better is arguing past the only evidence available.
The practical read for a US buyer: a well-formulated NMN product in the 250–900 mg range sits inside the span every published NMN trial has tested. Nothing in the literature yet justifies paying more for a dose above that ceiling. Our how much NMN per day breakdown walks that ladder rung by rung.
Why TMG Belongs in the Conversation
Every time your body processes NMN into NAD+ and clears the by-products, methylation pathways do part of the work, and those pathways run on methyl groups. TMG (trimethylglycine, also called betaine anhydrous) is a methyl donor, which is why experienced users have long bought it as a second bottle alongside bare NMN.
This is a formulation argument rather than a trial result — no published trial has tested NMN with TMG against NMN alone. It is worth knowing because it changes what you are actually comparing on a shelf. A bare-NMN bottle and an NMN + TMG bottle are not the same product at the same price, and comparing their per-milligram cost as if they were will mislead you.
AgeAura Pure NMN + TMG NAD+ Complex builds the pairing into one capsule set. Its panel lists 500 mg NMN and 250 mg TMG per two-capsule serving, alongside 150 mg quercetin, 100 mg trans-resveratrol, 50 mg apigenin and 1 mg spermidine, in a 60-capsule bottle at 30 servings. The spermidine is derived from wheat germ extract, so the product contains wheat — check that against your own allergen list before buying. We cover the pairing in more depth in NMN and TMG together.
Buying NMN or NR in the US: What to Check on the Label
Four checks separate a defensible US purchase from an expensive one.
- Read the serving, not the headline. A bottle advertising 500 mg often means 500 mg across two capsules. The panel is the truth; the front of the label is marketing.
- Count servings, not capsules. A 60-capsule bottle at two capsules a day is a 30-day supply. That is the number that determines your real monthly cost.
- Check whether TMG is included or sold separately. A cheaper bare-NMN bottle plus a separate TMG bottle can cost more than a combined formula.
- Ignore milligram-maximalism. As the dose gap above shows, the published NMN trials tested 250–900 mg. Paying a premium above that range buys you a number, not evidence.
On price, NAD+ precursors in the US generally sit between roughly $30 and $200 a bottle depending on dose, capsule count and what else is in the formula. On our own store the AgeAura NMN line runs from $59.95 to $159.99 across formats. You can browse the AgeAura collection or see what is moving in best sellers — both are browse suggestions, not a claim that any particular SKU sits inside either one.
See the full ingredient panel →
Frequently Asked Questions
Is NMN or NR better for raising NAD+?
Both raise NAD+ in humans, and that specific outcome is not in dispute for either. NR proved oral bioavailability first (Trammell 2016) and raised NAD+ metabolism across a 12-week crossover trial (Martens 2018). NMN raised blood NAD+ significantly at 300, 600 and 900 mg, with the highest levels at 600 and 900 mg (Yi 2023). If raising the marker is your only goal, either works. The trials separate on what happens beyond the marker.
Do NMN and NR have side effects?
Across all six trials here, neither compound produced a safety signal. The 12-week NR trial at 2,000 mg a day reported normal safety blood tests and no serious adverse events (Dollerup 2018). All 80 participants in the NMN dose-ladder trial completed it with no safety issues found at 300, 600 or 900 mg (Yi 2023). These are small, short trials in mostly healthy adults, so they say little about years of use. If you take prescription medication, are pregnant or nursing, or manage a chronic condition, talk to your own clinician first.
Can you take NMN and NR together?
No published human trial has tested the combination, so there is no evidence to describe either a benefit or a risk. Both convert into the same NAD+ pool, so stacking them mostly means paying twice to feed one pathway. If you are choosing between them rather than buying both, the trial evidence above is the more useful basis.
How long does NMN take to do anything?
In the dose-ladder trial, blood NAD+ was already significantly elevated at the first measurement point, day 30, and six-minute walking distance had improved against placebo by that same day-30 mark (Yi 2023). The insulin-sensitivity trial ran 10 weeks before measuring its endpoint (Yoshino 2021). A month is a reasonable first checkpoint; judging it after a week is judging nothing. See when to take NMN for timing.
Where can I buy NMN in the US?
Wellness Nest ships NMN across the United States from wellnessnest.co, with the AgeAura line running $59.95 to $159.99 depending on format. Check the current product page for shipping options and timing at the time you order. If you are comparing longevity compounds more broadly, our urolithin A dosage guide reads the trial ladder the same way this one does.
Does NMN need TMG?
No trial has tested that question directly. The reasoning is mechanistic: converting NMN and clearing its by-products draws on methylation pathways that run on methyl groups, and TMG is a methyl donor. Enough long-term users buy TMG separately that combined formulas now exist, which mainly matters for how you compare prices between bottles.
About the Author
Dr. Marcus Hale — Dr. Marcus Hale is the resident health researcher behind Wellness Nest's editorial team, translating peer-reviewed sports-nutrition and longevity research into practical daily guidance for US readers.
